A detailed history of Private Advisor Group, LLC transactions in Exscientia PLC stock. As of the latest transaction made, Private Advisor Group, LLC holds 28,123 shares of EXAI stock, worth $136,115. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,123
Previous 30,223 6.95%
Holding current value
$136,115
Previous $154,000 11.04%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$4.26 - $6.0 $8,946 - $12,600
-2,100 Reduced 6.95%
28,123 $137,000
Q2 2024

Aug 05, 2024

BUY
$3.99 - $6.04 $10,198 - $15,438
2,556 Added 9.24%
30,223 $154,000
Q1 2024

Apr 30, 2024

BUY
$5.3 - $7.51 $27,385 - $38,804
5,167 Added 22.96%
27,667 $158,000
Q4 2023

Feb 06, 2024

BUY
$4.35 - $6.88 $52,199 - $82,560
12,000 Added 114.29%
22,500 $144,000
Q2 2023

Aug 09, 2023

BUY
$4.79 - $8.3 $50,295 - $87,150
10,500 New
10,500 $62,000

Others Institutions Holding EXAI

About Exscientia plc


  • Ticker EXAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,461,000
  • Market Cap $593M
  • Description
  • Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...
More about EXAI
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.